Mar 03, 2020
Rothman Orthopaedics Surgeon Specializing in Rare Bone and Soft Tissue Cancers to Lead Capital Health's Sarcoma and Orthopaedic Oncology Program
Jan 30, 2020
Soft Tissue Sarcoma Market Size is Expected to Increase With a CAGR of 6.47% During Study Period for 7MM as per DelveInsight's Analysis
Oct 14, 2019
STA To Market Sarcoma Drug In Australia, New Zealand And SE Asia Following License Deal
Jul 02, 2019
Monopar Therapeutics and the Spanish Sarcoma Group (GEIS) Team Up on Phase 2 Sarcoma Trial With Monopar's Novel Camsirubicin
Nov 01, 2018
Global Sarcoma Drugs Market, 2017-2023 - New Product Launches, Increasing Adoption of Novel Therapeutics, and Growing Target Population
Sep 25, 2018
American Academy of Orthopaedic Surgeons endorses the Musculoskeletal Tumor Society's appropriate use criteria that informs doctors' monitoring of bone and soft tissue sarcoma survivors
Sep 24, 2018
Sarcoma Drugs Market Size Worth $1.2 Billion by 2023 | CAGR: 8.5%: Grand View Research, Inc.
Jun 21, 2018
PharmaEngine Announces Positive Topline Results from Global Pivotal Trial of PEP503 (NBTXR3) in Soft Tissue Sarcoma
Jun 21, 2018
CytRx Corporation Highlights Review of NantCell Inc's Aldoxorubicin Published in Future Oncology
May 30, 2018
Polaris Group Announces Treatment of First Patient in a Phase 2 Study of ADI-PEG 20 Plus Gemcitabine and Docetaxel for Soft Tissue Sarcoma
Feb 08, 2018
ESMO Sarcoma & GIST Symposium: Teleconsulting to Bring Specialised Expertise in Rare Cancers Across Europe